

| Variable | Effect on Required DMG Dosage |
| Target shelf life | Longer shelf life → higher dosage |
| Flour protein content | Higher protein → slightly lower DMG needed (less starch dilution) |
| Added protein ingredients | Higher added protein → higher DMG needed (more competition for starch interface) |
| DMG monoglyceride purity | Lower purity → higher dosage needed (recalculate on active MG content) |
| Alpha-gel vs. dry powder | Alpha-gel → same or lower dosage for equivalent effect |
| Baking temperature and time | Higher temperature → more effective complexation (higher dosage less critical) |
| Market | Designation | Label Declaration |
| USA | GRAS — 21 CFR 184.1505 | "Mono- and diglycerides" |
| EU | E471 | "Mono- and diglycerides of fatty acids" |
| JECFA (WHO/FAO) | ADI "not specified" | — |